Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Sunshine Guojian Pharmaceutical"
Count: 27
Selected: 0
NCT IDTitle
NCT04445038Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection
NCT05536726A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
NCT05520177A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss
NCT05641558Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT04527718Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
NCT05604898A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis
NCT05544591Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis
NCT05588908A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
NCT05584306A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma
NCT05528679A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma
NCT05193214A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma
NCT05145179A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors
NCT05138146A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma
NCT05027373Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
NCT04466254Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
NCT04922151601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
NCT04667910601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)
NCT04667897601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)
NCT03998345Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
NCT04468997The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)
NCT04367441Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects
NCT04345458Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis
NCT03950297Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A
NCT04151407The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
NCT03980379Pharmacokinetics, Efficacy and Safety of the 304 Injection
NCT03356158A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
NCT04079374Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel